29 related articles for article (PubMed ID: 30556879)
1. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3.
Li LW; Xiao HQ; Ma R; Yang M; Li W; Lou G
Int J Mol Med; 2018 Mar; 41(3):1529-1535. PubMed ID: 29286064
[TBL] [Abstract][Full Text] [Related]
2. miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.
Liao Z; Wang X; Liang H; Yu A; Ur Rehman U; Fan Q; Hu Y; Wang C; Zhou Z; Wang T
Cancer Med; 2017 Dec; 6(12):2957-2965. PubMed ID: 29034995
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer.
Soheilyfar S; Velashjerdi Z; Sayed Hajizadeh Y; Fathi Maroufi N; Amini Z; Khorrami A; Haj Azimian S; Isazadeh A; Taefehshokr S; Taefehshokr N
J BUON; 2018; 23(5):1290-1296. PubMed ID: 30570849
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-615-5p regulates the proliferation and apoptosis of breast cancer cells by targeting HSF1.
Liu K; Ma R
Exp Ther Med; 2021 Mar; 21(3):192. PubMed ID: 33488801
[TBL] [Abstract][Full Text] [Related]
5. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX.
Ye L; Feng W; Weng H; Yuan C; Liu J; Wang Z
Cancer Cell Int; 2020 Dec; 20(1):591. PubMed ID: 33298078
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
[TBL] [Abstract][Full Text] [Related]
7. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.
Wong JS; Cheah YK
Noncoding RNA; 2020 Jul; 6(3):. PubMed ID: 32668603
[TBL] [Abstract][Full Text] [Related]
8. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
9. miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2.
Değerli E; Torun V; Cansaran-Duman D
Biol Res; 2020 May; 53(1):19. PubMed ID: 32366289
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
11. MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4.
Qi W; Gao C; Zhang L; Gao Z; Sui J; Han C; Sun D
Am J Cancer Res; 2019; 9(12):2665-2678. PubMed ID: 31911853
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
Rahman MM; Brane AC; Tollefsbol TO
Cells; 2019 Oct; 8(10):. PubMed ID: 31597272
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-765 alleviates the malignant progression of breast cancer via interacting with EZH1.
Zeng Z; Yang Y; Wu H
Am J Transl Res; 2019; 11(7):4500-4507. PubMed ID: 31396353
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-3196 suppresses cell proliferation and induces cell apoptosis through targeting ERBB3 in breast cancer.
Ji ZC; Han SH; Xing YF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8383-8390. PubMed ID: 30556879
[TBL] [Abstract][Full Text] [Related]
15. miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer.
Yan X; Chen X; Liang H; Deng T; Chen W; Zhang S; Liu M; Gao X; Liu Y; Zhao C; Wang X; Wang N; Li J; Liu R; Zen K; Zhang CY; Liu B; Ba Y
Mol Cancer; 2014 Sep; 13():220. PubMed ID: 25248370
[TBL] [Abstract][Full Text] [Related]
16. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
17. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
18. MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1.
Du HY; Liu B
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2697-2706. PubMed ID: 29771421
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs as Next-generation Therapy Vehicles in Breast Cancer.
Thakur P; Dahiya H; Kaushal A; Gupta VK; Saini AK; Saini RV
Curr Gene Ther; 2023; 23(5):330-342. PubMed ID: 37728084
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
